Beyond Disclosure: Financial Conflicts of Interest and the Structural Integrity of Scientific Research

The current paper proposes the Financial Influence on Research Ecosystem (FIRE) Framework as a conceptual model, not a validated measurement instrument. It organises financial influence across seven interconnected domains: research agenda formation, funding and contractual arrangements, methodological architecture, data generation and analysis, interpretation and reporting, publication and dissemination, and translation into policy and practice. The strongest empirical support reviewed concerns biomedical and pharmaceutical research; application to artificial intelligence, environmental research and other fields is presently more provisional and requires discipline-specific validation. The framework distinguishes established empirical associations from plausible mechanisms and framework-generated propositions. Disclosure remains necessary but insufficient, and the paper proposes structural safeguards involving research contracts, independent statistical analysis, prospective registration, open science, data accessibility, institutional governance, journal transparency and diversified research financing. Protecting scientific integrity requires moving beyond the question of whether researchers have financial conflicts towards examining how financial incentives and decision-making authority may be embedded throughout systems of knowledge production.

research ethics; research misconduct; financial conflicts of interest; industry sponsorship; scientific integrity; commercialisation; publication bias; research funding; questionable research practices; biomedical research

1. Ahmed, N., & Wahed, M. (2020). The de-democratization of AI: Deep learning and the compute divide in artificial intelligence research. arXiv. https://doi.org/10.48550/arXiv.2010.15581 [Google Scholar] [Crossref]

2. Bekelman, J. E., Li, Y., & Gross, C. P. (2003). Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA, 289(4), 454–465. [Google Scholar] [Crossref]

3. https://doi.org/10.1001/jama.289.4.454 [Google Scholar] [Crossref]

4. Çaparlar, C. Ö., & Dönmez, A. (2016). What is Scientific Research and How Can it be Done? Turkish Journal of Anaesthesiology and Reanimation, 44(4), 212. https://doi.org/10.5152/TJAR.2016.34711 [Google Scholar] [Crossref]

5. Centers for Disease Control and Prevention. (2026, May 26). About scientific integrity. [Google Scholar] [Crossref]

6. https://www.cdc.gov/scientific-integrity/php/about/index.html [Google Scholar] [Crossref]

7. Cosgrove, L., Shaughnessy, A. F., Peters, S. M., Lexchin, J. R., Bursztajn, H. J., Bero, L., & D'Ambrozio, G. (2024). Undisclosed financial conflicts of interest in DSM-5-TR: Cross sectional analysis. BMJ, 384, e076902. https://doi.org/10.1136/bmj-2023-076902 [Google Scholar] [Crossref]

8. Cristea, I. A., & Ioannidis, J. P. A. (2018). Improving disclosure of financial conflicts of interest for research on psychosocial interventions. JAMA Psychiatry, 75(6), 541–542. [Google Scholar] [Crossref]

9. https://doi.org/10.1001/jamapsychiatry.2018.0382 [Google Scholar] [Crossref]

10. Davis, L. C., Diianni, A. T., Drumheller, S. R., Elansary, N. N., D’Ambrozio, G. N., Herrawi, F., Piper, B. J., & Cosgrove, L. (2024). Undisclosed financial conflicts of interest in DSM-5-TR: Cross sectional analysis. BMJ, 384, e076902. https://doi.org/10.1136/bmj-2023-076902 [Google Scholar] [Crossref]

11. Diaba-Nuhoho, P., & Amponsah-Offeh, M. (2021). Reproducibility and research integrity: The role of scientists and institutions. BMC Research Notes, 14, 451. https://doi.org/10.1186/s13104-021-05875-3 [Google Scholar] [Crossref]

12. Dwan, K., Gamble, C., Williamson, P. R., & Kirkham, J. J. (2013). Systematic review of the empirical evidence of study publication bias and outcome reporting bias—An updated review. PLOS ONE, 8(7), e66844. https://doi.org/10.1371/journal.pone.0066844 [Google Scholar] [Crossref]

13. Elmore, S. A., & Weston, E. H. (2020). Predatory journals: What they are and how to avoid them. Toxicologic Pathology, 48(4), 607–610. https://doi.org/10.1177/0192623320920209 [Google Scholar] [Crossref]

14. Graham, S. S., Majdik, Z. P., Clark, D., & Kessler, M. M. (2023). Relationships among commercial practices and author conflicts of interest in biomedical publishing. PLOS ONE, 18(7), e0287544. [Google Scholar] [Crossref]

15. Graham, S. S., Majdik, Z. P., Clark, D., Kessler, M. M., Hooker, T. B., Smith, S., & Tan, X. (2022). Evidence for stratified conflicts of interest policies in research contexts: A methodological review. BMJ Open, 12(9), e063501. https://doi.org/10.1136/bmjopen-2022-063501 [Google Scholar] [Crossref]

16. Grant, M. J., & Booth, A. (2009). A typology of reviews: An analysis of 14 review types and associated methodologies. Health Information & Libraries Journal, 26(2), 91–108. [Google Scholar] [Crossref]

17. https://doi.org/10.1111/j.1471-1842.2009.00848.x [Google Scholar] [Crossref]

18. Hundemer, S., Loizzo, J., Peterson, A. L., et al. (2026). Scientific objectivity and the pursuit of the public good. Science and Engineering Ethics, 32, Article 33. https://doi.org/10.1007/s11948-026-00601-3 [Google Scholar] [Crossref]

19. Institute of Medicine. (2009). Conflict of interest in medical research, education, and practice. The National Academies Press. https://doi.org/10.17226/12598 [Google Scholar] [Crossref]

20. International Committee of Medical Journal Editors. (n.d.). Clinical trials. [Google Scholar] [Crossref]

21. https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html [Google Scholar] [Crossref]

22. Krimsky, S. (2013). Do financial conflicts of interest bias research? An inquiry into the “funding effect” hypothesis. Science, Technology, & Human Values, 38(4), 566–587. [Google Scholar] [Crossref]

23. https://doi.org/10.1177/0162243912456271 [Google Scholar] [Crossref]

24. Lundh, A., Barbateskovic, M., Hróbjartsson, A., & Gøtzsche, P. C. (2010). Conflicts of interest at medical journals: The influence of industry-supported randomised trials on journal impact factors and revenue—Cohort study. PLoS Medicine, 7(10), e1000354. [Google Scholar] [Crossref]

25. https://doi.org/10.1371/journal.pmed.1000354 [Google Scholar] [Crossref]

26. Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017). Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews, 2017(2), MR000033. [Google Scholar] [Crossref]

27. https://doi.org/10.1002/14651858.MR000033.pub3 [Google Scholar] [Crossref]

28. Mezhoud, S. (n.d.). The concept of scientific research: Its types and morals. Abdelhafid Boussouf University Centre of Mila. [Google Scholar] [Crossref]

29. https://elearning.univmila.dz/a2024/pluginfile.php/111889/mod_resource/content/1/%20Research%20methodology%20and%20teaching%20pedagogy.pdf [Google Scholar] [Crossref]

30. National Academies of Sciences, Engineering, and Medicine. (2017). Fostering integrity in research. The National Academies Press. https://doi.org/10.17226/21896 [Google Scholar] [Crossref]

31. National Research Council & Institute of Medicine. (2002). Integrity in research. In Integrity in scientific research: Creating an environment that promotes responsible conduct. National Academies Press. NCBI Bookshelf chapter [Google Scholar] [Crossref]

32. Nguyen, L. T., & Tuamsuk, K. (2025). Factors influencing researchers’ scientific integrity in scholarly publishing: A path analysis approach. Research Ethics. https://doi.org/10.1177/17470161241257445 [Google Scholar] [Crossref]

33. Norris, S. L., Holmer, H. K., Ogden, L. A., & Burda, B. U. (2011). Conflict of interest in clinical practice guideline development: A systematic review. PLoS ONE, 6(10), e25153. [Google Scholar] [Crossref]

34. https://doi.org/10.1371/journal.pone.0025153 [Google Scholar] [Crossref]

35. Nosek, B. A., Spies, J. R., & Motyl, M. (2012). Scientific utopia: II. Restructuring incentives and practices to promote truth over publishability. Perspectives on Psychological Science, 7(6), 615–631. [Google Scholar] [Crossref]

36. https://doi.org/10.1177/1745691612459058 [Google Scholar] [Crossref]

37. Office of Research Integrity. (n.d.). Definition of research misconduct. U.S. Department of Health and Human Services. https://ori.hhs.gov/definition-research-misconduct [Google Scholar] [Crossref]

38. Pachter, W. S., Fox, R. E., Zimbardo, P., & Antonuccio, D. O. (2007). Corporate funding and conflicts of interest: A primer for psychologists. American Psychologist, 62(9), 1005–1015. [Google Scholar] [Crossref]

39. https://doi.org/10.1037/0003-066X.62.9.1005 [Google Scholar] [Crossref]

40. Purdue University College of Science. (n.d.). What is research? Purdue University. [Google Scholar] [Crossref]

41. https://www.purdue.edu/science/careers/find_internship_research/getting_started_with_research/what_is_research.html [Google Scholar] [Crossref]

42. Redman, B. K. (2023). Rebalancing commercial and public interests in prioritizing biomedical, health, and health care research. Accountability in Research. [Google Scholar] [Crossref]

43. Resnik, D. B. (2007). The price of truth: How money affects the norms of science. Oxford University Press. [Google Scholar] [Crossref]

44. Resnik, D. B. (2023). Disclosing and managing non-financial conflicts of interest in scientific publications. Research Ethics, 19(2), 121–138. https://doi.org/10.1177/17470161221148387 [Google Scholar] [Crossref]

45. Resnik, D. B., & Elliott, K. C. (2019). Value-entanglement and the integrity of scientific research. Studies in History and Philosophy of Science Part A, 75, 1–11. [Google Scholar] [Crossref]

46. https://doi.org/10.1016/j.shpsa.2018.12.011 [Google Scholar] [Crossref]

47. Shamoo, A. E., & Resnik, D. B. (2022). Responsible conduct of research (4th ed.). Oxford University Press. https://doi.org/10.1093/oso/9780197547090.001.0001 [Google Scholar] [Crossref]

48. Sismondo, S. (2007). Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLOS Medicine, 4(9), e286. [Google Scholar] [Crossref]

49. https://doi.org/10.1371/journal.pmed.0040286 [Google Scholar] [Crossref]

50. Sismondo, S. (2010). Publication ethics and the ghost management of medical publication. Bioethics, 23(8), 403–413. [Google Scholar] [Crossref]

51. Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of Business Research, 104, 333–339. https://doi.org/10.1016/j.jbusres.2019.07.039 [Google Scholar] [Crossref]

52. Song, F., Parekh, S., Hooper, L., Loke, Y. K., Ryder, J., Sutton, A. J., Hing, C., Kwok, C. S., Pang, C., & Harvey, I. (2010). Dissemination and publication of research findings: An updated review of related biases. Health Technology Assessment, 14(8), iii, ix–xi, 1–193. https://doi.org/10.3310/hta14080 [Google Scholar] [Crossref]

53. Taichman, D. B., Sahni, P., Pinborg, A., Peiperl, L., Laine, C., James, A., Hong, S.-T., Haileamlak, A., Gollogly, L., Godlee, F., Frizelle, F. A., Florenzano, F., Drazen, J. M., Bauchner, H., Baethge, C., Backus, J., & Mello, M. M. (2020). Data sharing statements for clinical trials: A requirement of the International Committee of Medical Journal Editors. Annals of Internal Medicine, 172(1), 63–65. [Google Scholar] [Crossref]

54. Torraco, R. J. (2005). Writing integrative literature reviews: Guidelines and examples. Human Resource Development Review, 4(3), 356–367. https://doi.org/10.1177/1534484305278283 [Google Scholar] [Crossref]

55. Viergever, R. F. (2013). The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: An overview of the problem, the causes, and solutions. Global Health Action, 6(1), 22450. https://doi.org/10.3402/gha.v6i0.22450 [Google Scholar] [Crossref]

56. Wedderkopp, N., & Rutz, E. (2024). Scientific Integrity and Transparency in Academic Writing: The Foundation of Credible Science. Children, 11(10), 1191. https://doi.org/10.3390/children11101191 [Google Scholar] [Crossref]

57. Whittemore, R., & Knafl, K. (2005). The integrative review: Updated methodology. Journal of Advanced Nursing, 52(5), 546–553. https://doi.org/10.1111/j.1365-2648.2005.03621.x [Google Scholar] [Crossref]

58. Woolf, S. H. (2008). The meaning of translational research and why it matters. JAMA, 299(2), 211–213. https://doi.org/10.1001/jama.2007.26 [Google Scholar] [Crossref]

59. World Medical Association. (2024a). WMA Declaration of Helsinki: Ethical principles for medical research involving human participants. World Medical Association.https://www.wma.net/policies-post/wma-declaration-of-helsinki/ [Google Scholar] [Crossref]

60. World Medical Association. (2024b). World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human participants. JAMA, 333(1), 71–74. [Google Scholar] [Crossref]

61. https://jamanetwork.com/journals/jama/fullarticle/2825290 [Google Scholar] [Crossref]

• A Study on Customer Awareness on Green Banking Intiatives
• International Financial Reporting Standards and Earnings Management: A Global Research Landscape Analysis
• Analysis of Financial Performance and Operational Efficiency of State Bank of India Using the CAMEL Framework
• Roles and Performance of India Post Payment Bank (IPPB) With Special References to Shivamogga District
• Enhancing Transactional Security in U.S. Banking Systems by Implementing OTP-Based Two-Factor Authentication to Mitigate Debit and Credit Card Fraud